Results of a Pilot Program to Improve Phosphorus Outcomes in Hemodialysis Patients

Journal of Renal Nutrition

Volumn 22, Issue 5, 2012, Pages 472-479

  Mayne, Tracy J ^a   Benner, Debbie ^a   Ricketts, Kathy ^b   Burgess, Mary ^a   Wilson, Steve ^a   Poole, Lynne ^c   Smyth, Michael ^c   Colson, Carey ^a   Krishnan, Mahesh ^a  

^a DAVITA CLINICAL RESEARCH   (United States)

^b Shire Pharmaceuticals   (United States)

^c Shire Pharmaceuticals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LANTHANUM; LANTHANUM CARBONATE; MINERAL; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN;

AGED; ARTICLE; BLOOD; BONE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NUTRITIONAL STATUS; PILOT STUDY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY;

AGED; BONE AND BONES; CALCIUM; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LANTHANUM; MALE; MIDDLE AGED; MINERALS; NUTRITIONAL STATUS; PARATHYROID HORMONE; PHOSPHORUS; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 84865366809     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.08.006     Document Type: Article

References (23)

1. Sigrist M.K., Taal M.W., Bungay P., McIntyre C.W. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007, 2:1241-1248.
2. Jean G., Bresson E., Terrat J.C., et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant 2009, 24:948-955.
3. Young E.W., Albert J.M., Satayathum S., et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005, 67:1179-1187.
4. Ganesh S.K., Stack A.G., Levin N.W., Hulbert-Shearon T., Port F.K. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001, 12:2131-2138.
5. Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004, 15:2208-2218.
6. CMS-1418-F, Medicare Program; End-Stage Renal Disease Prospective Payment System. August 12, 2010.
7. Isakova T., Gutierrez O.M., Chang Y., et al. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 2009, 20:388-396.
8. Shinaberger C.S., Greenland S., Kopple J.D., et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. Am J Clin Nutr 2008, 88:1511-1518.
9. Danese M.D., Belozeroff V., Smirnakis K., Rothman K.J. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 2008, 3:1423-1429.
10. Doumas B.T., Watson W.A., Biggs H.G. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971, 31:87-96.
11. Gotch F.A. Kinetic modeling in hemodialysis. Clinical Dialysis 1995, 156-189. Prentice Hall, Englewood Cliffs, NJ. A.R. Nissenson, F.N. Fine, D.E. Gentile (Eds.).
12. Talke H., Schubert G.E. Enzymatic urea determination in the blood and serum in the Warburg optical test [in German]. Klin Wochenschr 1965, 43:174-175.
13. Beyer L. Will the new ESRD payment bundle signal the end of rural hospital-based dialysis clinics?. Nephrol News Issues 2010, 24:38-40.
14. Roach J.L., Turenne M.N., Hirth R.A., Wheeler J.R., Sleeman K.S., Messana J.M. Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls. Am J Kidney Dis 2010, 56:928-936.
15. Crafton D. The ESRD bundle creates a perfect storm. Nephrol News Issues 2010, 24:36-38.
16. Sullivan J.D. The changing tide in ESRD care. Nephrol News Issues 2010, 24:27-28.
17. Sedor J.R., Watnick S., Patel U.D., et al. ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities. J Am Soc Nephrol 2010, 21:1235-1237.
18. Turenne M.N., Hirth R.A., Messana J.M., Turner J.S., Sleeman K.K., Wheeler J.R. When payment systems collide: the effect of hospitalization on anemia in renal dialysis patients. Med Care 2010, 48:296-305.
19. Kristensen C., Wish J. The 2009 proposed rule for prospective ESRD payment: perspectives from the forum of ESRD networks. Am J Kidney Dis 2010, 55:234-236.
20. Bhat J.G., Bhat P. The 2009 proposed rule for prospective ESRD payment: perspectives from a for-profit small dialysis organization. Am J Kidney Dis 2010, 55:231-233.
21. Moran J. The 2009 proposed rule for prospective ESRD payment: perspectives from a medium-sized dialysis organization. Am J Kidney Dis 2010, 55:227-228.
22. Nissenson A.R., Mayne T.J., Krishnan M. The 2009 proposed rule for prospective ESRD payment: perspectives from a large dialysis organization. Am J Kidney Dis 2010, 55:223-226.
23. Wish D. Revisions in the end stage renal disease prospective payment system: implications for nephrology nurses. Nephrol Nurs J 2009, 36:635-641.